title: 8th Nottingham International Breast Cancer Conference, Nottingham, UK, 16-19 September 2003.
abstract: The four-day biennial 8th Nottingham Breast Cancer Conference held at the East Midlands Conference Centre, University of Nottingham, UK (16-19 September 2003) once again proved to be a successful event. Recent advances in clinical and scientific research were presented to an international audience, covering a broad spectrum of breast cancer issues including prediction, diagnosis and treatment. Delegates were encouraged to participate in workshop sessions, which allowed the comprehensive discussion of existing and promising future advances in breast cancer care.
authors.affiliation: Molecular Medicine Unit, St James's University Hospital, Leeds, UK. j.l.limer@leeds.ac.uk
authors.forename: Jane L
authors.initials: JL
authors.lastname: Limer
authors.forename: Alicia T
authors.initials: AT
authors.lastname: Parkes
authors.forename: Alison
authors.initials: A
authors.lastname: Waterworth
authors.forename: Claire E
authors.initials: CE
authors.lastname: Murphy
authors.forename: Cathy R
authors.initials: CR
authors.lastname: Tait
authors.forename: Caroline J
authors.initials: CJ
authors.lastname: Witton
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D013629:Tamoxifen / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D017273:Goserelin